ArticleTrials2023

Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial.

Xiangyang Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.